Ares Capital's Non-Accruals Rose to 2.4% of Its Portfolio, Still Below Its Own Historical Average

Ares Capital’s non-accrual loans rose to 2.4% in Q2 2026 from 1.8% a year earlier (up 60 bps YoY), a directionally negative shift for loan-credit quality. The article argues the level remains manageable—below Ares Capital’s ~3% Great Recession-era historical average and well under the industry ~4%—so it’s not yet viewed as a portfolio problem. Investors should continue monitoring for a move toward/above 3% if the trend persists, given the risk to its ~9.5% yield.

Analysis

For a BDC, rising non-accruals matter less as a current income hit than as an early warning on NAV erosion and future dividend coverage. The key second-order effect is funding: if ARCC's credit metrics soften while spread income stays stable, the market can re-rate the whole BDC complex lower, making it harder for smaller lenders to access equity capital at attractive discounts. That matters most for less diversified peers and any borrower cohort tied to the same stressed end-markets.

Near term, this is more of a monitoring issue than a sell signal. The real catalyst window is the next 1-3 quarters: watch non-accrual migration, PIK income, realized losses, and whether management leans on fee income or leverage to defend the payout. If non-accruals push through 3% and keep rising, the market will start assuming the problem is cyclical rather than idiosyncratic, which would pressure the dividend multiple and the stock's premium/discount to NAV.

Contrarian take: the market may be too eager to declare this benign because it compares ARCC to its own long-run average, not to where credit losses typically accelerate after a prolonged high-rate period. But the base case is still "watch, don't panic" unless underwriting metrics worsen again. The cleaner expression is relative value, not a naked short: if ARCC stabilizes while weaker credit-sensitive BDCs lag, the dispersion trade should work better than a sector-wide directional bet.

Key Decisions for Investors

• No outright short ARCC here; wait for the next quarterly update. A decisive short only makes sense if non-accruals break above 3% and PIK/realized losses rise together.
• For relative value, long ARCC vs short BIZD on any indiscriminate BDC selloff; ARCC's stronger balance-sheet franchise should outperform if the theme is 'credit scare without systemic deterioration.'
• If Q3 data confirm worsening credit, switch to long BXSL/TSLX or MAIN vs short ARCC; target 5-10% relative spread with a 1-2 quarter horizon.
• Set an alert on ARCC dividend coverage and NAV per share; a coverage ratio miss or NAV markdown is the first falsifier of the 'still fine' narrative.